• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎:两名无反应者在停止治疗数月后病毒清除

Chronic hepatitis C: viral clearance several months after discontinuation of therapy in two non-responders.

作者信息

Denis J, Rautou P E, Lambare B, Herbert S, Auray-Cartier V, Asselah T

机构信息

Service d'Hépato-Gastroenterologie, Centre Hospitalier Sud-Francilien, quartier du Canal-Courcouronnes, 91014 Evry Cedex, France.

出版信息

Infection. 2007 Jun;35(3):197-200. doi: 10.1007/s15010-007-6099-7.

DOI:10.1007/s15010-007-6099-7
PMID:17565465
Abstract

When hepatitis C virus (HCV) infection becomes chronic, spontaneous viral eradication is a rare event. We report two patients with chronic hepatitis C, non-responders to standard interferon alone. They were treated with Pegylated interferon plus ribavirin. At the end of therapy, HCV RNA was still detectable. Several months after stopping treatment, aminotransferase level normalized and HCV RNA became undetectable. No case of sustained viral response happening several months after therapy has been yet described. During long-term follow-up of non-responders, when a persistent normalization of aminotransferase level is observed after stopping treatment, viral clearance could be suspected.

摘要

当丙型肝炎病毒(HCV)感染转为慢性时,病毒自发清除的情况极为罕见。我们报告了两名慢性丙型肝炎患者,他们对单独使用标准干扰素治疗无反应。他们接受了聚乙二醇化干扰素联合利巴韦林治疗。治疗结束时,HCV RNA仍可检测到。停止治疗数月后,转氨酶水平恢复正常,HCV RNA检测不到。尚未有关于治疗数月后出现持续病毒学应答的病例报道。在对无反应者的长期随访中,当停止治疗后观察到转氨酶水平持续正常时,可能怀疑病毒已清除。

相似文献

1
Chronic hepatitis C: viral clearance several months after discontinuation of therapy in two non-responders.慢性丙型肝炎:两名无反应者在停止治疗数月后病毒清除
Infection. 2007 Jun;35(3):197-200. doi: 10.1007/s15010-007-6099-7.
2
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.利巴韦林对1型丙型肝炎患者接受聚乙二醇化干扰素α-2a加利巴韦林治疗反应的影响。
Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24.
3
Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.接受聚乙二醇干扰素α-2b和利巴韦林治疗的慢性丙型肝炎患者早期丙型肝炎病毒RNA变化
Rev Invest Clin. 2003 Mar-Apr;55(2):138-42.
4
[Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C].[聚乙二醇化干扰素α-2B联合利巴韦林再治疗儿童慢性丙型肝炎的早期病毒学应答]
Przegl Epidemiol. 2006;60(1):71-7.
5
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.慢性丙型肝炎患者(而非肝细胞癌患者)甲胎蛋白升高的预测因素及其在聚乙二醇化干扰素α-2a-利巴韦林联合治疗后的恢复正常情况。
J Gastroenterol Hepatol. 2007 May;22(5):669-75. doi: 10.1111/j.1440-1746.2007.04898.x.
6
Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎儿童的早期病毒学应答
Infection. 2007 Jun;35(3):175-9. doi: 10.1007/s15010-007-6072-5.
7
[Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C].聚乙二醇干扰素和利巴韦林治疗儿童慢性丙型肝炎的效果
Przegl Epidemiol. 2005;59(2):491-8.
8
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.隐匿性乙肝病毒感染与慢性丙型肝炎联合治疗早期丙型肝炎病毒复制的抑制
J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.
9
Peginterferon alpha-2b plus ribavirin with or without amantadine [correction of amantidine] for the treatment of non-responders to standard interferon and ribavirin.聚乙二醇干扰素α-2b联合利巴韦林,加或不加金刚烷胺用于治疗对标准干扰素和利巴韦林无反应者。 [原词amantidine有误,此处应为amantadine]
Antivir Ther. 2004 Aug;9(4):499-503.
10
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.聚乙二醇干扰素α-2a(40KD)联合利巴韦林治疗基因2型或3型慢性丙型肝炎患者16或24周。
Gastroenterology. 2005 Aug;129(2):522-7. doi: 10.1016/j.gastro.2005.05.008.

引用本文的文献

1
Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents.模拟直接作用抗病毒药物治疗结束后免疫衰竭逆转如何引发慢性丙型肝炎的治愈。
Immunol Cell Biol. 2018 Oct;96(9):969-980. doi: 10.1111/imcb.12161. Epub 2018 Jun 5.
2
Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.慢性丙型肝炎病毒1b型患者接受聚乙二醇干扰素加利巴韦林治疗6周后病毒清除延迟
Case Rep Gastroenterol. 2016 Aug 9;10(2):417-422. doi: 10.1159/000448072. eCollection 2016 May-Aug.
3
Lower-Dose and Long-Term Intermittent Interferon Therapy for Hepatitis C Genotype 2a may be a Possibility.
低剂量和长期间歇性干扰素治疗丙型肝炎2a基因型可能是一种选择。
Int J Biomed Sci. 2008 Sep;4(3):245-7.
4
Hepatitis C virus clearance after discontinuation of pegylated interferon alpha-2a monotherapy in a child.一名儿童停用聚乙二醇化干扰素α-2a单药治疗后丙型肝炎病毒清除情况
Case Rep Med. 2012;2012:597348. doi: 10.1155/2012/597348. Epub 2012 Oct 18.
5
Delayed viral clearance of chronic hepatitis C in patients after treatment failure.慢性丙型肝炎治疗失败后患者病毒清除延迟。
Gut Liver. 2011 Mar;5(1):110-4. doi: 10.5009/gnl.2011.5.1.110. Epub 2011 Mar 16.